SIOGEN Biotech voted ‘Most Innovative Biotech in Asia’ at BioPharma Industry Awards 2011
Dr. Shermal Perera, Managing Director of SIOGEN, said, “Winning this award is further validation that Siosomes® can enable the improved, targeted delivery of a broad range of therapeutic agents. It is an exciting time for SIOGEN as our technology and creative partnering have led to a pipeline of smart therapeutics with indications in diseases ranging from tuberculosis to cancer. We are currently seeking joint venture partners and investment to set up our operations in the US, to expand our NanoVesicle technology into other markets.”
Nominations were invited from across the industry and more than 40,000 votes were cast to decide the award winners. In the ‘Most Innovative Biotech’ category, five companies were shortlisted on the basis of their innovation and novel approach in developing drugs. SIOGEN was voted the winner for its Siosomes® NanoVesicle platform technology and the creative collaborations it has established with research institutions, pharma and biotech companies worldwide.
Most read news
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.